Mohammad Ghaffarloo, M.D.
Endocrinology, Diabetes & Metabolism Physician in Clinton Township, Michigan.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 7,871 in Endocrinology, Diabetes & Metabolism Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Mohammad Ghaffarloo, M.D. reported a CMS MIPS final score of 18.2/100 - below the 83.5 national average - and filed 11,988 Medicare Part D claims in 2023.
- 18.2/100
- MIPS score · -65 vs avg
- 12K
- Part D claims, 2023
- 67%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
CMS NPPES provider registry desk
NPI 1275631764 · Endocrinology, Diabetes & Metabolism Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-HEAVY · BOOK-THIN · PHOTO-FINISH
- NPI-10 1275631764
- ENUM-LEGACY 2006
- TAX-MID 8K Endocrinology, Diabetes
- MIPS-LOW 18.2/100
- RX-HEAVY 12K claims
- BOOK-THIN 164 in Michigan
- PHOTO-FINISH Anthony Jennings · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Anjanette Tan · …
Anjanette Tan
18 MIPS pts
- Ghaffarloo · thi…
Ghaffarloo · this provider
18.2 MIPS pts
- Anthony Jennings…
Anthony Jennings
18.3 MIPS pts
- Jose Ortiz · hig…
Jose Ortiz
18.4 MIPS pts
- Robert Castelluc…
Robert Castellucci
18.4 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Mohammad Ghaffarloo, M.D.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
18 ≥ 2nd percentile 2% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Mohammad Ghaffarloo, M.D. sits
This provider among endocrinology, diabetes & metabolism physician peers
Across the 2,341 endocrinology, diabetes & metabolism physician providers who report both Medicare Part D prescribing and a MIPS quality score, Mohammad Ghaffarloo, M.D. writes more Part D claims than 98% of them and scores higher on MIPS quality than 2% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one endocrinology, diabetes & metabolism physician peer from a representative sample of 60; the gold marker is Mohammad Ghaffarloo, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Mohammad Ghaffarloo, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Mohammad Ghaffarloo, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Michigan
How Endocrinology, Diabetes & Metabolism Physician compares to other specialties among Michigan providers
Endocrinology, Diabetes & Metabolism Physician ranks #117 among Michigan's specialties (0.1% of in-state providers)
Each bar is a specialty's share of the Michigan provider total, by primary NUCC taxonomy. The highlighted bar is Endocrinology, Diabetes & Metabolism Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Mohammad Ghaffarloo, M.D.'s 2023 MIPS final score plotted against the Endocrinology, Diabetes & Metabolism Physician national average
- MIPS Final Score
- 18.2/100
- vs 83.5 national avg · 2023 performance year
Quality benchmarks
- National MIPS avg 2023 measured reporting year
- Quality dim CMS Quality category
- Cost dim CMS Cost category
- Specialty volume Endocrinology, Diabetes & Metabolism Physician US NPIs
18.2/100 MIPS final score - 65.3 pts below the 83.5 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Endocrinology, Diabetes & Metabolism Physician. Quality dim: 0. Cost dim: 60.7.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1275631764 |
|---|---|
| Specialty | Endocrinology, Diabetes & Metabolism Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 09/20/2006 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Mohammad Ghaffarloo, M.D.'s current license status, disciplinary history, and board certifications with the Michigan Department of Licensing and Regulatory Affairs in Michigan before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1275631764 is the unique 10-digit identifier CMS uses to link Ghaffarloo across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Individual
Hospital and facility affiliations
Facilities where Mohammad Ghaffarloo, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
License & disciplinary context - Michigan MI-BOM 2023 annual report
Aggregate state board data only, NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~41K Michigan medical licensees in 2023 - they are NOT specific to Mohammad Ghaffarloo, M.D.. To verify Mohammad Ghaffarloo, M.D.'s current license status, search the MI-BOM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.
MI-BOM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Michigan disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.
Brand vs generic prescribing mix · Above average
29% brand-name claims vs 67% generic, on 11,988 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 28,164
- Total Day Supply
- 823,358
- Brand vs Generic
- 29% brand / 67% generic
- Brand Drug Cost
- $3.8M
- Generic Drug Cost
- $247K
- Opioid Claims
- 134 (1.1% rate)
- Antibiotic Claims
- 336
Patient Demographics
- Average Patient Age
- 71.8 years
- Avg HCC Risk Score
- 1.82
- Gender Split
- 60% female / 40% male
- Age Distribution
- <65: 187, 65-74: 381, 75-84: 307, 85+: 113
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Mohammad Ghaffarloo, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Levothyroxine Sodium
Levothyroxine Sodium
835 claims
- Metformin Hcl
Metformin Hcl
752 claims
- Atorvastatin Calcium
Atorvastatin Calcium
510 claims
- Ozempic
Ozempic
381 claims
- Trulicity 327
Trulicity
327 claims
- Lisinopril 297
Lisinopril
297 claims
- Amlodipine Besylate 256
Amlodipine Besylate
256 claims
- Furosemide 241
Furosemide
241 claims
| Drug | Claims |
|---|---|
| Levothyroxine Sodium | 835 |
| Metformin Hcl | 752 |
| Atorvastatin Calcium | 510 |
| Ozempic Semaglutide | 381 |
| Trulicity Dulaglutide | 327 |
| Lisinopril | 297 |
| Amlodipine Besylate | 256 |
| Furosemide | 241 |
| Novolog Flexpen Insulin Aspart | 232 |
| Metoprolol Succinate | 228 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Endocrinology, Diabetes & Metabolism Physician Overview
How Mohammad Ghaffarloo, M.D. fits within the Endocrinology, Diabetes & Metabolism Physician landscape nationally.
Mohammad Ghaffarloo, M.D.'s 11,988 claims are above the specialty average of 2,639.
Nationwide Endocrinology, Diabetes & Metabolism Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ghaffarloo, both outside Michigan so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (18.2 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Endocrinology, Diabetes & Metabolism Physician Providers in Michigan
Other clinicians with the same primary specialty enrolled in Michigan, drawn from the same CMS NPPES roster as Ghaffarloo.
One of 164 Endocrinology, Diabetes & Metabolism Physician providers enrolled in Michigan, 5 are shown here.
Compare Endocrinology, Diabetes & Metabolism Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Mohammad Ghaffarloo, M.D.'s specialty? ▼
How much does Mohammad Ghaffarloo, M.D. prescribe under Medicare Part D? ▼
What is Mohammad Ghaffarloo, M.D.'s Medicare quality score? ▼
Where is Mohammad Ghaffarloo, M.D. located? ▼
What is Mohammad Ghaffarloo, M.D.'s NPI number? ▼
Does Mohammad Ghaffarloo, M.D. prescribe more brand-name or generic drugs? ▼
Does Mohammad Ghaffarloo, M.D. prescribe opioids? ▼
How many Endocrinology, Diabetes & Metabolism Physician providers are there in the US? ▼
What drugs does Mohammad Ghaffarloo, M.D. prescribe most often? ▼
Does Mohammad Ghaffarloo, M.D. accept Medicare? ▼
How can I verify Mohammad Ghaffarloo, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.